May 26, 2015
The Ministry of Health, Labor and Welfare (MHLW) issued a notification on May 25 granting orphan drug designation for Zenyaku Kogyo’s rituximab (recombinant) and Ono Pharmaceutical’s metirosine. Rituximab was given the designation for the prevention of antibody-associated rejections in ABO...read more